Leslie L Popplewell (Leslie Popplewell)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Histone Deacetylase

Top Venues

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Matthew G Mei, Lu Chen, James K Godfrey, Joo Y Song, Colt A Egelston, L Elizabeth Elizabeth Budde, Saro H Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, Peter Lee, Robert W Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Jasmine Zain, Steven T Rosen, Stephen J Forman, Leslie L Popplewell, Larry W Kwak, Alex F Herrera
Pembrolizumab plus vorinostat is highly active in Hodgkin lymphoma, including patients refractory to prior PD-1 blockade. Blood (2023)
Tycel Jovelle Phillips, David A Bond, Radhika Takiar, Karson J Kump, Malathi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria R Nachar, Ryan A Wilcox, Shannon Ann Carty, Yasmin H Karimi, Zaneta Nikolovska-Coleska, Mark S Kaminski, Alex F Herrera, Kami Maddocks, Leslie L Popplewell, Alexey V Danilov
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma. Blood advances (2023)
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, L Elizabeth Elizabeth Budde, Matthew G Mei, Tanya Siddiqi, Leslie L Popplewell, Yi-Ping Wen, Jasmine M Zain, Stephen J Forman, Larry W Kwak, Steven T Rosen, Alexey V Danilov, Alex F Herrera, Nikhil Thiruvengadam
Cost Effectiveness of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-cell Lymphoma. Blood (2022)
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, L Elizabeth Elizabeth Budde, Matthew G Mei, Leslie L Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen J Forman, Larry W Kwak, Steven T Rosen, Alexey V Danilov, Alex F Herrera, Nikhil R Thiruvengadam
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma. Blood 140 (19) (2022)
Joo Y Song, Anamarija M Perry, Alex F Herrera, Lu Chen, Pamela Skrabek, Michel R Nasr, Rebecca A Ottesen, Janet Nikowitz, Victoria Bedell, Joyce Murata-Collins, Yuping Li, Christine McCarthy, Raju Pillai, Jinhui Wang, Xiwei Wu, Jasmine Zain, Leslie L Popplewell, Larry W Kwak, Auayporn P Nademanee, Joyce C Niland, David W Scott, Qiang Gong, Wing C Chan, Dennis D Weisenburger
Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2021)
Xiuli Wang, Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim, Vibhuti Vyas, Wen-Chung Chang, Brenda Aguilar, Alfonso Brito, Aniee Sarkissian, N Achini Bandara, Lu Yang, Jinhui Wang, Xiwei Wu, Jianying Zhang, Saul J Priceman, Hong Qin, Larry W Kwak, Lihua E Budde, Sandra H Thomas, Mary C Clark, Leslie L Popplewell, Tanya Siddiqi, Christine E Brown, Stephen J Forman
The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma. Cancer immunology research 9 (1) (2020)
Daniel O Persky, Hongli Li, Lisa M Rimsza, Paul M Barr, Leslie L Popplewell, Charles L Bane, Ann Von Gehr, Michael LeBlanc, Richard I Fisher, Sonali M Smith, Jonathan W Friedberg
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806. American journal of hematology 93 (4) (2018)